What is NDC 65862-134?

65862-134 is the product NDC for Hydrochlorothiazide, Hydrochlorothiazide 50 mg/1 tablet, listed with the FDA by Aurobindo Pharma Limited. It has 2 package NDCs, shown above in 10- and 11-digit form.

Aurobindo Pharma Limited, NDC labeler code 65862. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Hydrochlorothiazide?

166 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Hydrochlorothiazide NDC 65862-134 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)65862-134Labeler and product segments. Claims need a package NDC.

Product NDC at billing width65862-0134Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
65862-134-01	6586201340165862013401	100 TABLET in 1 BOTTLE (65862-134-01)Marketed from Jul 20, 2007
65862-134-99	6586201349965862013499	1000 TABLET in 1 BOTTLE (65862-134-99)Marketed from Jul 20, 2007

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Hydrochlorothiazide
Generic name (nonproprietary): hydrochlorothiazide
Active ingredients: Hydrochlorothiazide — 50 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Aurobindo Pharma LimitedNDC labeler code 65862
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 040780
Marketing start: Jul 20, 2007
Listing expires: Dec 31, 2027
Other FDA classes: Increased Diuresis (Physiologic effect)Thiazides (Chemical structure)
Identifiers: Product ID 65862-134_db5cdbe8-1cd9-4bc3-a9b3-4fb4f053db3eSPL ID db5cdbe8-1cd9-4bc3-a9b3-4fb4f053db3eSPL set ID 01f1f478-5493-439f-9b99-f4f82023781cRxCUI 197770, 310798UNII 0J48LPH2TH
Pharmacologic class: Thiazide Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N465862013401 followed by a unit qualifier and the quantity

Package 65862-0134-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 26, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE Hydrochlorothiazide tablets, USP are indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. Hydrochlorothiazide tablets, USP have also been found useful in edema due to various forms of renal dysfunction such as nephrotic syndrome, acute glomerulonephritis, and chronic renal failure. Hydrochlorothiazide tablets, USP are indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension. Use in Pregnancy Routine use of diuretics during normal pregnancy is inappropriat…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 65862-134

What is NDC 65862-134?: 65862-134 is the product NDC for Hydrochlorothiazide, Hydrochlorothiazide 50 mg/1 tablet, listed with the FDA by Aurobindo Pharma Limited. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Hydrochlorothiazide.
What is the active ingredient?: Hydrochlorothiazide.
Who is the labeler?: Aurobindo Pharma Limited, NDC labeler code 65862. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Hydrochlorothiazide?: 166 other product NDCs are listed under this name. See all Hydrochlorothiazide NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Hydrochlorothiazide NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Hydrochlorothiazide	Hydrochlorothiazide 50 mg/5mL	SolutionOral	Advagen Pharma Ltd	72888-491	72888-0491-01
Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1	TabletOral	Teva Pharmaceuticals, Inc.	0480-3444	00480-3444-10
hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1	CapsuleOral	Preferred Pharmaceuticals Inc.	68788-4192	68788-4192-0168788-4192-0368788-4192-06+2 more
Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1	TabletOral	REMEDYREPACK INC.	70518-4736	70518-4736-00
Hydrochlorothiazide	Hydrochlorothiazide 25 mg/1	TabletOral	Unit Dose Solutions, Inc.	87441-038	87441-0038-01
Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1	TabletOral	Coupler LLC	67046-1664	67046-1664-03
Hydrochlorothiazide	Hydrochlorothiazide 25 mg/1	TabletOral	American Health Packaging	60687-894	60687-0894-01
Hydrochlorothiazide	Hydrochlorothiazide 50 mg/1	TabletOral	REMEDYREPACK INC.	70518-4525	70518-4525-00
Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1	TabletOral	REMEDYREPACK INC.	70518-4466	70518-4466-0070518-4466-01
Hydrochlorothiazide	Hydrochlorothiazide 25 mg/1	TabletOral	REMEDYREPACK INC.	70518-4359	70518-4359-0070518-4359-0170518-4359-02+2 more

All 167 Hydrochlorothiazide NDCs